Servizio Comunitario di Informazione in materia di Ricerca e Sviluppo - CORDIS

Le informazioni sui progetti di Orizzonte 2020 e ora anche le relative sintesi delle relazioni sono disponibili su CORDIS. Tutti i progetti H2020 possono essere scaricati dal Portale Open Data dell'UE .

My refinements

Download results of this page

Perfeziona per:

Advanced search

Cerca progetti e risultati

Results 1 - 10 of 21
Order by: Results/page:
12 3 > 
Sensing and controlling single molecules by novel electrical, mechanical and optical methods with applications to nanobiotechnology
ID: QLK3-CT-2001-00278
Data di inizio: 2002-01-01, Termine: 2004-12-31
This project concerns controlling and sensing single bio molecules by means of Nan electrodes and laser spectroscopy. First, the molecular position and orientation between systems of Nan electrodes will be sensed and controlled. The Nan electrodes will also act as "antennas" i...
Record Number: 64192
Last updated on: 2012-06-12
Development of antimicrobial peptides as novel anti-infective drugs
ID: QLK2-CT-2000-00411
Data di inizio: 2000-09-01, Termine: 2003-08-31
The rapid spread of antibiotic resistance requires innovative anti-infective drugs and strategies. The PANAD concept proposes to develop potent antimicrobialpeptides (Amps) to the preclinical stage of investigation. Natural and designed Amps will first be extensively screened ...
Record Number: 54643
Last updated on: 2005-04-12
Development of human dopaminergic neuronal cell lines for transplantation
ID: QLK3-CT-2001-02120
Data di inizio: 2001-11-01, Termine: 2004-10-31
Parkinson's disease (PD) affects >1M people in the EU, and is a source of significant suffering and costs to the Community. Unlike available medical therapy, restoration of function has been demonstrated in patients receiving fatal grafts containing developing dopaminergic cel...
Record Number: 70551
Last updated on: 2005-04-12
Genetics education: improving non-genetic health professionals' understanding of genetic testing (GENED)
ID: QLG4-CT-2001-30216
Data di inizio: 2001-12-01, Termine: 2005-05-31
New genetics information and technologies are expanding rapidly. The rate of increase of trained medical geneticists and counsellors has not kept pace with genetic discoveries and demand for services. As genetic testing moves into mainstream health care tests will be administe...
Record Number: 60030
Last updated on: 2005-04-12
Role of cytokines and growth factors in cartilage destruction in osteoarthritis
ID: QLK6-CT-1999-02072
Data di inizio: 2000-03-01, Termine: 2003-05-31
Record Number: 51572
Last updated on: 2005-04-12
Fragrance chemical allergy: a major environmental and consumer health problem in europe
ID: QLK4-CT-1999-01558
Data di inizio: 2000-02-01, Termine: 2003-03-31
Sensitivity to fragrance ingredients is acknowledged as a common and clinically important problem in Europe. At least 1-2% of the general population is allergic (delayed hypersensitivity) to standard indicators of fragrance chemical allergy, which makes contact sensitisation t...
Record Number: 52810
Last updated on: 2005-04-12
Heterocyclic amines in cooked foods - role in human health
ID: QLK1-CT-1999-01197
Data di inizio: 2000-02-01, Termine: 2003-05-31
Carcinogenic heterocyclic amines (HAs) are formed at ppb level during cooking of meat and fish. Epidemiological studies have shown a correlation between the intake of fried meat and cancer. The carcinogen city of HAs has been shown in mice, rats and non-human primates. The hum...
Record Number: 51480
Last updated on: 2005-04-12
Cartridges with molecularly imprinted recognition elements for antibiotic residues monitoring in milk
ID: QLK1-CT-1999-00902
Data di inizio: 2000-02-01, Termine: 2003-01-31
Bacteria exposed excessively to antibiotics may develop resistance. To ensure our future capacity in fighting infectious diseases it is therefore of vital importance to decrease the spread of antibiotics globally. Antibiotics are commonly used in veterinary medicine. Simple an...
Record Number: 51478
Last updated on: 2005-04-12
Preclinical evaluation of delivery systems for neuroprotective gene therapy in neurodegenerative diseases.
ID: QLK3-CT-1999-00702
Data di inizio: 2000-03-01, Termine: 2004-03-01
The long-term objective is to provide a comprehensive pre-clinical background for neuroprotective therapies, using gene therapy delivery systems developed by European biotechnology companies, in patients with neurodegenerative diseases. Experimental studies have pointed to th...
Record Number: 52107
Last updated on: 2005-04-12
Novel in vitro testing platforms based on intra-and extracellular sensing
ID: QLK3-CT-2001-00244
Data di inizio: 2002-01-01, Termine: 2004-12-31
The goal of the project is to develop new in-vitro platforms for pharmaceutical screening based on animal or human cells grown on microelectrode arrays enabling simultaneous monitoring of extra- and intracellular levels of key metabolites (e.g., NO and super oxide) by using op...
Record Number: 64198
Last updated on: 2005-04-12
12 3 > 
List retrieved on: 2018-05-27